Quantcast

Latest Cancer treatments Stories

2013-06-02 23:15:45

Voices Against Brain Cancer comments on a potential new target that gives promise for treating glioblastomas. New York, NY (PRWEB) June 01, 2013 On June 1, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a possible new target that may enhance brain cancer treatment. According to a Futurity.org article, researchers are working on targeting a specific enzyme that may be able to inhibit and kill glioblastoma cells and other forms of...

2013-06-02 23:01:05

A promising, new cancer immunotherapy combination treatment showing long term survival for patients with metastatic melanoma was highlighted today at the American Society of Clinical Oncology Annual Meeting in Chicago. (PRWEB) June 02, 2013 A promising, new cancer immunotherapy combination treatment showing long term survival for patients with metastatic melanoma was highlighted today at the American Society of Clinical Oncology Annual Meeting in Chicago. Results form a phase II study...

2013-05-30 23:14:29

FDA Review in SITC's Journal for ImmunoTherapy of Cancer offers new insights into cancer immunotherapy product development & clinical evaluation. Milwaukee, WI (PRWEB) May 30, 2013 A picture of what the FDA is looking for in cancer immunotherapy product development appears in an extensive new review article published in the inaugural issue of the Journal for ImmunoTherapy of Cancer. Providing a US regulatory perspective on pre-clinical to first in man studies, the review is described...

Melanoma Treatments Receive FDA Approval
2013-05-30 12:43:33

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) has approved two new medicines used to treat the most dangerous form of skin cancer, as well as a genetic test developed alongside those drugs. The two new medications, both of which are manufactured by GlaxoSmithKline (GSK), are dabrafenib (which will be marketed as Tafinlar) and trametinib (which will be sold under the name Mekinist). They will be used to treat patients with advanced...

2013-05-28 23:04:09

Treatment with ipilimumab can result in durable antitumor effects despite a low overall response rate in patients with advanced mucosal melanoma (MM). Richard D. Carvajal, MD, Medical Oncologist at the Memorial Sloan-Kettering Cancer Center in New York, led the multicenter, retrospective study, recently published in The Oncologist, in collaboration with researchers from the Dana-Farber Cancer Institute and Massachusetts General Hospital in Boston. Durham, NC (PRWEB) May 28, 2013 Treatment...

2013-05-27 10:43:58

Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ignore cancer cells. Regulatory T cells are immune cells that function to suppress the immune system response. In this issue of the Journal of Clinical Investigation, researchers led by Ronald Levy at Stanford University found that regulatory T cells that infiltrate tumors...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.